primary hepatocellular carcinoma
Conditions
Interventions
C-TACE:Iodized oil-TACE
CalliSphere-TACE:CalliSphere-TACE
HepaSphere-TACE:HepaSphere-TACE
Sponsors
The Second Affiliated Hospital of Harbin Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.The patient was over 18 years old; 2.Primary HCC patients diagnosed by histology; 3.Patients with child-Pugh A or B, BCLC stage A or B, ECOG score 0-2, and no TACE related contraindications.
Exclusion criteria
Exclusion criteria: 1.Patients who can not cooperate with follow-up information collection (such as psychiatric history, inaccurate answers); 2.Contraindications for TACE: severe liver dysfunction (child-Pugh C), including jaundice, hepatic encephalopathy, refractory ascites or hepatorenal syndrome; renal dysfunction; severe coagulation dysfunction; complete obstruction of the main portal vein with few collateral vessels; 3.Cachexia or multiple organ failure; 4.Allergic to local anesthetics, contrast agents or chemotherapy drugs; 5.Pregnant women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| RECIST;PFS;OS;OS; | — |
Secondary
| Measure | Time frame |
|---|---|
| routine blood test;Biochemical indexes;AFP;complications; | — |
Countries
China
Contacts
Public ContactShi Zhongxing
The Second Affiliated Hospital of Harbin Medical University
Outcome results
None listed